At a glance | 2000 | 2011 | 2021 | 2030 | 2045 | |||||
---|---|---|---|---|---|---|---|---|---|---|
Diabetes estimates (20-79 y) | ||||||||||
People with diabetes, in 1,000s | - | - | - | - | - | |||||
Age-adjusted comparative prevalence of diabetes, % | - | - | - | - | - | |||||
People with undiagnosed diabetes, in 1,000s | - | - | - | - | - | |||||
Proportion of people with undiagnosed diabetes, % | - | - | - | - | - | |||||
Impaired glucose tolerance (IGT) estimates (20-79 y) | ||||||||||
People with IGT, in 1,000s | - | - | - | - | - | |||||
Age-adjusted comparative prevalence of IGT, % | - | - | - | - | - | |||||
Mortality attributable to diabetes (20-79 y) | ||||||||||
Deaths attributable to diabetes | - | - | - | - | - | |||||
Proportion of diabetes-related deaths in people under 60 y, % | - | - | - | - | - | |||||
Type 1 diabetes estimates in children and adolescents | ||||||||||
New cases of type 1 diabetes (0-14 y), in 1,000s | - | - | - | - | - | |||||
New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | - | - | - | |||||
Type 1 diabetes (0-14 y), in 1,000s | - | - | - | - | - | |||||
Type 1 diabetes (0-19 y), in 1,000s | - | - | - | - | - | |||||
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||||||||
Live births affected by HIP | - | - | - | - | - | |||||
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - | - | |||||
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - | - | |||||
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - | - | |||||
Diabetes-related health expenditure | ||||||||||
Total diabetes-related health expenditure, USD million | - | - | - | - | - | |||||
Total diabetes-related health expenditure, ID million | - | - | - | - | - | |||||
Diabetes-related health expenditure per person, USD | - | - | - | - | - | |||||
Diabetes-related health expenditure per person, ID | - | - | - | - | - | |||||
Demographics | ||||||||||
Total adult population (20-79 y), in 1,000s | - | - | - | - | - | |||||
Population of children (0-14 y), in 1,000s | - | - | - | - | - | |||||
Population of children and adolescents (0-19 y), in 1,000s | - | - | - | - | - | |||||
Impaired fasting glucose (IFG) estimates (20-79 y) | ||||||||||
People with IFG, in 1,000s | - | - | - | - | - | |||||
Age-adjusted comparative prevalence of IFG, % | - | - | - | - | - |